Cartesian Therapeutics, Inc. SEC filings RNAC
Cartesian Therapeutics, Inc. has 876 filings in SEC EDGAR's recent list, going back to Jan 5, 2009. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 13, 2025 | — |
| EFFECT | Filing | Jan 13, 2025 | — |
| EFFECT | Filing | Jan 8, 2025 | — |
| EFFECT | Filing | Jan 8, 2025 | — |
| EFFECT | Filing | Jan 8, 2025 | — |
| CORRESP | Letter to the SEC | Jan 6, 2025 | — |
| CORRESP | Letter to the SEC | Jan 6, 2025 | — |
| CORRESP | Letter to the SEC | Jan 6, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2024 | — |
| EFFECT | Filing | Oct 1, 2024 | — |
| CORRESP | Letter to the SEC | Sep 27, 2024 | — |
| CORRESP | Letter to the SEC | Sep 20, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2024 | — |
| CORRESP | Letter to the SEC | Sep 9, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2024 | — |
| D | Filing | Jul 17, 2024 | — |
| 8-A12G | Filing | Dec 8, 2023 | — |
| D/A | Filing | Dec 4, 2023 | — |
| EFFECT | Filing | Dec 1, 2023 | — |
| D | Filing | Dec 1, 2023 | — |
| CORRESP | Letter to the SEC | Dec 1, 2023 | — |
| CORRESP | Letter to the SEC | Oct 30, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 30, 2023 | — |
| NT 10-Q | Filing | Aug 14, 2023 | Jun 30, 2023 |
| DEFR14A | Filing | May 3, 2022 | — |
| D | Filing | Aug 18, 2020 | — |
| EFFECT | Filing | Aug 14, 2020 | — |
| CORRESP | Letter to the SEC | Aug 12, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2020 | — |
| CT ORDER | Filing | May 12, 2020 | — |
| EFFECT | Filing | Feb 6, 2020 | — |
| CORRESP | Letter to the SEC | Feb 4, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2020 | — |
| D | Filing | Jan 2, 2020 | — |
| CT ORDER | Filing | Dec 13, 2019 | — |
| CT ORDER | Filing | Dec 13, 2019 | — |
| D | Filing | Sep 4, 2019 | — |
| CT ORDER | Filing | Apr 30, 2019 | — |
| EFFECT | Filing | Aug 28, 2017 | — |
| CORRESP | Letter to the SEC | Aug 24, 2017 | — |
| CT ORDER | Filing | Aug 23, 2017 | — |
| EFFECT | Filing | Jul 21, 2017 | — |
| CORRESP | Letter to the SEC | Jul 20, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2017 | — |
| D | Filing | Jul 11, 2017 | — |
| CT ORDER | Filing | Jun 7, 2017 | — |
| CT ORDER | Filing | May 8, 2017 | — |
| CT ORDER | Filing | Mar 3, 2017 | — |
| D | Filing | Dec 14, 2016 | — |
| CERTNAS | Auto-generated paper document | Jun 28, 2016 | — |
| CT ORDER | Filing | Jun 23, 2016 | — |
| EFFECT | Filing | Jun 21, 2016 | — |
| CORRESP | Letter to the SEC | Jun 17, 2016 | — |
| CORRESP | Letter to the SEC | Jun 17, 2016 | — |
| CORRESP | Letter to the SEC | Jun 10, 2016 | — |
| 8-A12B | Filing | Jun 8, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2016 | — |
| CORRESP | Letter to the SEC | Jun 6, 2016 | — |
| CORRESP | Letter to the SEC | Jun 6, 2016 | — |
| CORRESP | Letter to the SEC | Jun 3, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2016 | — |
| CORRESP | Letter to the SEC | May 31, 2016 | — |
| DRS/A | Filing | Apr 27, 2016 | — |
| DRS/A | Filing | Mar 30, 2016 | — |
| DRS/A | Filing | Mar 18, 2016 | — |
| DRSLTR | Filing | Dec 29, 2015 | — |
| DRS/A | Filing | Dec 29, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2015 | — |
| DRS | Filing | Nov 24, 2015 | — |
| D | Filing | Sep 10, 2015 | — |
| D | Filing | Apr 23, 2015 | — |
| D | Filing | Aug 28, 2014 | — |
| D | Filing | Jul 15, 2014 | — |
| D | Filing | Apr 9, 2014 | — |
| D | Filing | Nov 17, 2011 | — |
| D | Filing | Nov 17, 2011 | — |
| D | Filing | Apr 6, 2010 | — |
| REGDEX | Auto-generated paper document | Jan 5, 2009 | — |
Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RNAC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Frederick, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1453687
- Former names
- SELECTA BIOSCIENCES INC (until Nov 13, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.